in order to provide the most complete and accurate data , a postmarketing surveillance program ( pmsp ) for auranofin ( af ) oral gold therapy for rheumatoid arthritis ( ra ) was conducted in the federal republic of germany ( frg ) from december 1982 through december 1985 .
C0004320
auranofin
C0003873
rheumatoid arthritis